Pages
Products
AAV4-Cre

AAV4-Cre

Cat.No. :  AAV00178Z

Titer: ≥1x10^12 GC/mL / ≥1x10^13 GC/mL Size: 30 ul/100 ul/500 ul/1 ml

Serotype:  AAV Serotype 4 Storage:  -80 ℃

Inquire for Price

AAV Particle Information

Quality Control

Cat. No. AAV00178Z
Description AAV serotype 4 particles contain Cre recombinase under CMV promoter.
Serotype AAV Serotype 4
Titer Varies lot by lot, typically ≥1x10^12 GC/mL
Size Varies lot by lot, for example, 30 μL, 50 μL, 100 μL etc.
Storage Store at -80℃. Avoid multiple freeze/thaw cycles.
Shipping Frozen on dry ice
Creative Biogene ensures high-quality AAV particles by optimizing and standardizing production protocols and performing stringent quality control (QC). The specific QC experiments performed vary between AAV particle lots.
Endotoxin Endotoxins, primarily derived from Gram-negative bacteria, can trigger adverse immune responses. Endotoxin contamination is a significant concern in the production of AAV, especially for applications in animal studies and gene therapy. Effective endotoxin quality control is essential in the development and manufacturing of AAV particles. Creative Biogene utilizes rigorous endotoxin detection methods to monitor the endotoxin level in our produced AAV particles to ensure regulatory compliance.
Purity AAV purity is critical for ensuring the safety and efficacy of AAV-based applications.AAV capsids are composed of three main protein components, known as viral proteins: VP1, VP2, and VP3. These proteins play a critical role in the structure and functionality of the AAV capsid. Monitoring the VP1, VP2, and VP3 content in AAV preparations is essential for quality control in AAV production. Our AAV particles are tested for showing three clear bands of VP1, VP2 VP3 by SDS-PAGE.
Sterility The AAV virus samples are inoculated into the cell culture medium for about 5 days to detect bacterial and fungal growth.
Transducibility Upon requirement, Creative Biogene can perform in vitro or in vivo transduction assays to evaluate the ability of AAV to deliver genetic material into target cells or tissues, and assess gene expression and functional activities.
Empty vs. Full Capsids Based-on our proprietary AAV production and purification technology, Creative Biogene can always offer AAV particles with high ratio of full capsids. If required, we can also assess the ratio for a specifc lot of AAV particles by transmission electron microscopy (TEM) or other methods.
Quick Inquiry

Background

Case Study

Publications

Q & A

Customer Reviews

Adeno-associated virus (AAV) belongs to the genus Dependoparvovirus of the family Parvoviridae. AAV is a promising vector for therapeutic gene delivery due to its wide variability in tissue tropism and transduction efficiency and lack of pathological features. To date, more than 100 natural AAV variants have been identified from various hosts and tissues, and its tropism has become one of the important features for its potential in clinical development. The genus Dependoparvovirus is divided into two monophyletic groups, one of which contains clades specific to humans (clades A, B, and C) and the other contains a mixture of clades isolated only from humans (clade F), only from non-human primates (clade D), or from humans and non-human primates (clade E). Representative serotypes include AAV1/6 (clade A), AAV2 (clade B), AAV2–3 hybrid (clade C), AAV7 (clade D), AAV8 (clade E), and AAV9 (clade F), while AAV3, AAV4, and AAV5 are designated as individual clones. Naturally occurring AAV utilizes glycan moieties for initial attachment to the cell surface, such as heparan sulfate proteoglycans (HSPGs) for AAV2/3/6, N-terminal galactose for AAV9, and sialic acid (SIA) moieties for AAV1/4/5/6. The adeno-associated virus receptor (AAVR), a glycosylated protein containing five polycystic kidney disease (PKD) repeat domains in its extracellular portion, has recently been identified as a key protein receptor for multiple AAV serotypes that exploits post-attachment events for viral entry.

Gene therapy using adeno-associated virus (AAV) vectors requires knowledge of their tropism in vivo. Here, researchers analyzed the tropism of ten naturally occurring AAV serotypes (AAV3B, AAV4, AAV5, AAV6, AAV7, AAV8, AAV9, AAVrh8, AAVrh10, and AAVrh74) after systemic delivery into male and female mice. Transgenes expressing ZsGreen and Cre recombinase were used to identify transduced cells in a cell-dependent manner based on fluorescence. Cre-driven tdTomato fluorescence activation provided excellent sensitivity for transduced cells. All serotypes, except AAV3B and AAV4, had high liver tropism. Fluorescence activation revealed transduction of unexpected tissues, including adrenal glands, testes, and ovaries. Rare transduced cells within tissues were also readily observed. Biodistribution of the AAV genome correlated with fluorescence, with the exception of immune tissues. The study found that AAV4 has pan-endothelial tropism and also targets pancreatic β cells.

Here, researchers generated AAV4 vectors expressing Cre recombinase. Intravenous injection of AAV4-Cre into Ai9 mice resulted in abundant tdTomato-positive signals in the lungs outside the airways (Figure 1A). Flow cytometry showed that the majority of tdTomato signals originated from endothelial cells based on CD31+/CD45- expression. Notably, >85% of lung endothelial cells were transduced by AAV4 in both male and female mice. In contrast, only about 20% of non-immune non-endothelial cells in the lung appeared to be transduced by AAV4 (Figure 1B). Repeating the experiment using an AAV4 vector expressing Cre demonstrated poor AAV4 transduction of the liver, showing only sparse TdTomato hepatocytes and possible signal in isolated liver sinusoidal endothelial cells. In stark contrast, impressive endothelial cell transduction was observed in the stomach, bladder, adrenal glands, pancreas, brain, small intestine, and thymus (Figure 1C). Furthermore, co-staining with insulin antibodies confirmed that AAV4 could effectively transduce β cells (Figure 1D).

AAV4 exhibits a unique tropism for endothelial cells and pancreatic beta cells.Figure 1. AAV4 exhibits a unique tropism for endothelial cells and pancreatic beta cells. (Walkey C J, et al., 2024)

Ask a Question

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

Customer Reviews
Highly recommended!

AAV4-Cre's ability to provide clear, localized expression of Cre recombinase has greatly enhanced our research outcomes, avoiding off-target effects and ensuring reliable data. Highly recommended!

French

02/17/2022

Write a Review

Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.

Needs improvement

Satisfaction

General satisfaction

Very satisfaction